RDS-04-010
RDS-04-010 is an atypical dopamine transporter (DAT) inhibitor. RDS-04-010 has the effect of inhibiting cocaine intake and seeking behavior. RDS-04-010 exerts its modulatory effect mainly by binding to the inward conformation of DAT, thereby reducing the reinforcing effect of cocaine. RDS-04-010 can be used in the study of cocaine use disorder (CUD) [1].
Product Specifications
CAS Number
2324109-06-8
UNSPSC
12352005
Target
Dopamine Transporter
Related Pathways
Neuronal Signaling
Field of Research
Neurological Disease
Purity
98.84
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
FC(C=C1)=CC=C1C(S(CCN2C[C@H](C)N(CC(C)O)[C@H](C)C2)=O)C3=CC=C(F)C=C3
Molecular Formula
C24H32F2N2O2S
Molecular Weight
450.58
References & Citations
[1]Soler-Cedeno O, et al. RDS-04-010: a novel atypical DAT inhibitor that inhibits cocaine taking and seeking and itself has low abuse potential in experimental animals. Transl Psychiatry. 2025 May 24;15 (1) :182.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
127027-APC 100 µL
FUT7 (Alpha- (1,3) -fucosyltransferase, Fucosyltransferase 7, Fuc-TVII, Fucosyltransferase VII, FucT-VII, Galactoside 3-L-fucosyltransferase, Selectin Ligand Synthase) (APC)
Sign In for Pricing
View Details